Anita is a Senior Scientist from Fluidigm; a biotech company that focuses on single-cell genomics and proteomics.
She focuses on supporting CyTOF, a Mass Cytometry platform that has been used widely in major health-related research areas like Cancer Immunotherapy (For example; By Nobel Prize winner Jim Allison’s lab), AIDS research; Allergy and Autoimmune diseases; Diabetes.
Anita did her PhD from Tata Cancer Center, Mumbai, India where she studied the molecular biology of the development of Chronic Myeloid Leukemia.
She joined Children’s Hospital Los Angeles as a Post-Doctoral Fellow in 1997, where she studied the role of SHIP phosphatase in regulation of myeloid response under the guidance of Dr. Don Durden. Later, she joined Dr. Bob Seeger’s group that was developing novel immunotherapies for neuroblastoma. Her work focused on the autologous transfer of immune cells, enriched from patients along with humanized antibody as a potential therapeutic platform for neuroblastoma.
Before joining Fluidigm, Anita worked for Neomarkers, Inc. (a Thermo fisher company) as a research manager and then at Molecular Devices, Inc., A Danaher company for 8 years as a Scientist and then as a Product Manager. She also started classroom and online versions of Molecular Devices University.